北京大学学报(医学版) ›› 2018, Vol. 50 ›› Issue (6): 1117-1119. doi: 10.19723/j.issn.1671-167X.2018.06.032

• 病例报告 • 上一篇    下一篇

原发性骨髓纤维化引起的继发性痛风1例

季兰岚,郝燕捷,张卓莉()   

  1. 北京大学第一医院风湿免疫科,北京 100034
  • 收稿日期:2018-07-09 出版日期:2018-12-18 发布日期:2018-12-18
  • 通讯作者: 张卓莉 E-mail:zhuoli.zhang@126.com

A case of gout secondary to primary myelofibrosis

Lan-lan JI,Yan-jie HAO,Zhuo-li ZHANG()   

  1. Department of Rheumatology and Immunology,Peking University First Hospital, Beijing 100034, China
  • Received:2018-07-09 Online:2018-12-18 Published:2018-12-18
  • Contact: Zhuo-li ZHANG E-mail:zhuoli.zhang@126.com

RICH HTML

  

摘要:

关键词: 继发性痛风, 痛风石, 原发性骨髓纤维化, 骨髓增殖性疾病

Abstract:

A 52-year-old man was referred to our department with a 2-year history of polyarthritis. He was diagnosed as gout due to acute arthritis of bilateral feet dorsum 2 years ago,but he didn’t receive any standard treatment. 1 year ago,there were more and more joints evolved during the gout attack,and many subcutaneous nodules occurred. When he presented to our clinic 1 month ago,the urate acid level was as high as 715 μmol/L. Moreover,we could find bone erosion in the X rays of his hand and foot,as well as synovitis,double contour sign and tophus on the ultrasound examination. The diagnosis of gout was clearly and definitely. However,he had leukocytosis and thrombocytosis for 4 years in the past history,and the urate acid level was only 400 μmol/L at that time. He also had well-controlled hypertension. The family history was unremarkable. Furthermore,we found megalosplenia on his physical examination. The bone marrow examination showed myelofibrosis and JAK2 V617F gene was positive. He was diagnosed as primary myelofibrosis and treated with interferon-α,together with urate acid-lowing therapy (febuxostat 60 mg once daily). Following-up for 1 year,the dosage of febuxostat decreased to 40 mg once daily,and the patient didn’t have gout attack again,some of the tophus diminished,and the urate acid level ranged from 400 to 500 μmol/L. Gout is a common disease in clinical practice,usually combined with metabolic syndrome,chronic renal failure and specific drugs using (diuretic and calcineurin inhibitors). However,it is relatively rare to see gout associated with myeloproliferative diseases,including polycythemia vera,primary thrombocythemia,primary myelofibrosis and chronic myelocytic leukemia.In these diseases,the turnover of nucleic acids is greatly augmented,and an excess of purine metabolites,including uric acid,is released. In the natural course of gout,the appearance of tophus from the first onset of arthritis usually takes several years. This patient only had one traditional risk factor,but his urate acid level was remarkably high and he developed tophus in a short term. After treatment of primary myelofibrosis,the symptom of gout partially alleviated. Careful physical examination and medical history taking lead to the diagnosis of secondary gout,which should be reminded in the daily practice.

Key words: Secondary gout, Tophus, Primary myelofibrosis, Myeloproliferative diseases

中图分类号: 

  • R593

图1

双手腕(A)及双足(B)X线片,箭头所指可见骨质破坏"

图2

左足距骨双轨征,左足距骨横断面扫查可见距骨上方双轨征形成(箭头)"

图3

右足痛风石,右足距舟关节上方可见一低-高混杂回声团块影,边界清晰,内可见点状多普勒血流信号(箭头)"

[1] 中华医学会风湿病学分会. 2016中国痛风诊疗指南[J]. 中华内科杂志, 2016,55(11):892-899.
[2] Neogi T, Jansen TLTA, Dalbeth N , et al. 2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative[J]. Ann Rheum Dis, 2015,74(10):1789-1798.
doi: 10.1136/annrheumdis-2015-208237 pmid: 4602275
[3] Yü TF . Secondary gout associated with myeloproliferative diseases[J]. Arthritis Rheum, 1965,8(5):765-771.
doi: 10.1002/art.1780080439 pmid: 5216775
[4] Gutman AB . The past four decades of progress in the knowledge of gout, with an assessment of the present status[J]. Arthritis Rheum, 1973,16(4):431-445.
doi: 10.1002/(ISSN)1529-0131
[5] Takahashi H, Hattori A, Shibata A . Profile of blood coagulation and fibrinolysis in chronic myeloproliferative disorders[J]. Tohoku J Exp Med, 1982,138(1):71-80.
doi: 10.1620/tjem.138.71 pmid: 6959382
[6] Barbui T, Carobbio A, Cervantes F , et al. Thrombosis in primary myelofibrosis: incidence and risk factors[J]. Blood, 2010,115(4):778-782.
doi: 10.1182/blood-2009-08-238956 pmid: 19965680
[7] Liu TT, Chen JB, Chen WJ , et al. Idiopathic myelofibrosis associated with renal extramedullary hematopoiesis and nephrotic syndrome: case report[J]. Chang Gung Med J, 2000,23(3):169-174.
pmid: 15641221
[1] 甘地, 付强, 唐小惠, 李楚炜, 舒兆平. 胸锁关节痛风1例[J]. 北京大学学报(医学版), 2026, 58(3): 670-673.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!